|
XRN2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.536000E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.441000E-01 |
| Normal-vs-Stage2 |
3.482200E-01 |
| Normal-vs-Stage3 |
1.801770E-01 |
| Normal-vs-Stage4 |
3.818200E-01 |
| Stage1-vs-Stage2 |
8.054800E-01 |
| Stage1-vs-Stage3 |
3.782600E-01 |
| Stage1-vs-Stage4 |
8.164000E-01 |
| Stage2-vs-Stage3 |
6.691600E-01 |
| Stage2-vs-Stage4 |
9.598000E-01 |
| Stage3-vs-Stage4 |
7.654000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.704200E-02 |
| Normal-vs-AfricanAmerican |
2.209600E-01 |
| Normal-vs-Asian |
5.077200E-01 |
| Caucasian-vs-AfricanAmerican |
7.608800E-01 |
| Caucasian-vs-Asian |
4.395400E-01 |
| AfricanAmerican-vs-Asian |
4.079800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.562800E-01 |
| Normal-vs-Female |
6.424300E-04 |
| Male-vs-Female |
3.077600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.887400E-01 |
| Normal-vs-Extreme_Weight |
9.074400E-01 |
| Normal-vs-Obese |
1.689710E-02 |
| Normal-vs-Extreme_Obese |
8.909200E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.485400E-01 |
| Normal_Weight-vs-Obese |
2.223000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.350200E-01 |
| Extreme_Weight-vs-Obese |
1.929520E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.111600E-01 |
| Obese-vs-Extreme_Obese |
2.261600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.889800E-02 |
| Normal-vs-Age(41-60Yrs) |
4.097400E-03 |
| Normal-vs-Age(61-80Yrs) |
4.983600E-01 |
| Normal-vs-Age(81-100Yrs) |
6.315800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.169000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.821900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.319770E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.492200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.89769999999446E-05 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.440800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.428300E-02 |
| Normal-VS-Type2 PRCC |
7.759600E-01 |
| Normal-VS-KIRP CIMP |
2.397200E-01 |
| Normal-VS-Unclassified PRCC |
1.308450E-02 |
| Type1 PRCC-VS-Type2 PRCC |
5.964200E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.998000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.406400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.723230E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.249860E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.516600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.089600E-01 |
| Normal-vs-N1 |
4.301700E-02 |
| Normal-vs-N2 |
9.689000E-01 |
| N0-vs-N1 |
6.395700E-02 |
| N0-vs-N2 |
9.582400E-01 |
| N1-vs-N2 |
3.876000E-01 |
|
|
